Moch Kenneth I
SEC-identified person · CIK 1070009 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Gamida Cell Ltd. GMDA | Director | filed 2022 - 2024 |
| Zynerba Pharmaceuticals, Inc. ZYNE | Director | filed 2015 - 2023 |
| Chimerix INC CRMX | Director · President and CEO | filed 2013 - 2014 |
| Emisphere Technologies INC EMIS | Director | filed 2009 - 2009 |
| Synvista Therapeutics, Inc. SYI | Director · CEO, President & Chairman | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.